RESUMEN
Dentinogenesis imperfecta (DGI) and dentin dysplasia (DD) are allelic disorders that primarily affect the formation of tooth dentin. Both conditions are autosomal-dominant and can be caused by mutations in the dentin sialophosphoprotein gene (DSPP, 4q21.3). We recruited 23 members of a four-generation kindred, including ten persons with dentin defects, and tested the hypothesis that these defects are linked to DSPP. The primary dentition showed amber discoloration, pulp obliteration, and severe attrition. The secondary dentition showed either pulp obliteration with bulbous crowns and gray discoloration or thistle-tube pulp configurations, normal crowns, and mild gray discoloration. Haplotype analyses showed no recombination between three 4q21-q24 markers and the disease locus. Mutational analyses identified no coding or intron junction sequence variations associated with affection status in DMP1, MEPE, or the DSP portion of DSPP. The defects in the permanent dentition were typically mild and consistent with a diagnosis of DD-II, but some dental features associated with DGI-II were also present. We conclude that DD-II and DGI-II are milder and more severe forms, respectively, of the same disease.
Asunto(s)
Cromosomas Humanos Par 4/genética , Displasia de la Dentina/genética , Dentina/fisiopatología , Dentinogénesis Imperfecta/genética , Proteínas de la Matriz Extracelular/genética , Adulto , Anciano , Análisis Mutacional de ADN , Displasia de la Dentina/clasificación , Displasia de la Dentina/fisiopatología , Dentinogénesis Imperfecta/clasificación , Dentinogénesis Imperfecta/fisiopatología , Dentición Permanente , Femenino , Ligamiento Genético , Glicoproteínas/genética , Humanos , Masculino , Persona de Mediana Edad , Linaje , Fenotipo , Fosfoproteínas/genética , Índice de Severidad de la Enfermedad , Sialoglicoproteínas/genéticaRESUMEN
Alkaloids are an important group of diversely distributed, chemically, biologically and commercially significant natural products. This article suggests why now, with the presently available technology, and the remaining biome available and reasonably accessible, is an opportune moment to consciously focus on the discovery of further alkaloids with pharmacophoric utility.